A process in which batches of compounds are tested for binding activity or biological activity against target molecules. High-throughput screening seeks to evaluate large numbers of compounds rapidly and in parallel. Compounds are tested as inhibitors of target enzymes, as competitors for binding of a natural ligand to its receptor, and as agonists or antagonists for receptor-mediated intracellular processes.
Glossary
High-Throughput Screening (HTS)
02.27.12
-
Breaking News | Drug Development | R&D
Veraxa Biotech and Indivumed to Jointly Develop Precision Oncology Antibody Drugs
Aim to discover new possibilities for cancer treatment in the shortest-possible time.
-
Breaking News | Industry News
CPI Scales Up Manufacturing of Pyocin S5
A promising treatment for lung infection in cystic fibrosis patients developed by the University of Glasgow.Contract Pharma Staff
-
Bio News | Bioanalytical Services | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Axxam and Fujifilm Cellular Dynamics Enter Alliance
Partner to deliver integrated hiPSC drug discovery solutions.Contract Pharma Staff
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis SA and OSE Immunotherapeutics Enter Pact
Sign agreement for the development of OSE's interleukin receptor 7 antagonist
